Recruiting studies: Early Lung Cancer Detection

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Integrating Telehealth to Advance Lung Cancer Screening
NA · 1 location(s) · Abramson Cancer Center at Penn Medicine · NCT06638554 Application of Methylation Markers in Early Detection and MRD Monitoring of Lung Cancer
Phase N/A · 1 location(s) · Beijing Haidian Hospital · NCT07257458 Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
Phase N/A · 36 location(s) · Freenome Holdings Inc. · NCT06122077 Study of Early Cancer Biomarkers in Breath Condensate in Population of Individuals With High-Risk of Lung Cancer Undergo
NA · 3 location(s) · The Institute of Molecular and Translational Medicine, Czech · NCT06016569 An Investigational Scan (Me-4FDG PET/CT) for the Detection of Sodium-Glucose Transport for Early Diagnosis of Lung Cance
Phase 1/Phase 2 · 1 location(s) · Jonsson Comprehensive Cancer Center · NCT05558904 CHAMP Lung Cancer Screening Program
NA · 3 location(s) · Jill Kolesar · NCT07572773 Identification and Validation of Blood-Based Biomarkers for Early Detection of Asymptomatic Lung Cancer in High-Risk Hea
Phase N/A · 1 location(s) · Everest Detection, Inc. · NCT06816121 The CCANED-CIPHER Study: Early Cancer Detection and Treatment Response Monitoring Using AI-Based Platelet and Immune Cel
Phase N/A · 4 location(s) · Javier Toledo · NCT06717295 Cohort Evaluation of Body Fluids Early Detection of Cancer in High-risk Individuals
NA · 1 location(s) · Gustave Roussy, Cancer Campus, Grand Paris · NCT06907095 Blood Based Risk Evaluation With AI for Targeted Primary Health Care in Early Lung Cancer Detection
NA · 2 location(s) · Vejle Hospital · NCT07552584 Rarecells Molecular Biomarkers for Early Detection of Lung Cancer
Phase N/A · 1 location(s) · Rarecells Diagnostics SAS · NCT06546007 Lung Cancer Screening Program in Mexico
Phase N/A · 1 location(s) · Instituto Nacional de Cancerologia de Mexico · NCT06535451 Developing Novel Circulating Epigenetic Biomarkers for Early Detection of Lung Cancer
Phase N/A · 1 location(s) · National Taiwan University Hospital · NCT04814407 Deep Learning Using Chest X-Rays to Identify High Risk Patients for Lung Cancer Screening CT
NA · 1 location(s) · Massachusetts General Hospital · NCT06910956 cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Phase N/A · 17 location(s) · Adela, Inc · NCT05366881 Collection of Sputum and Labeling for Lung Cancer
Phase N/A · 3 location(s) · bioAffinity Technologies Inc. · NCT03457415 Improving Detection of Early Lung Cancer in a Diverse Population (IDEAL) Study
NA · 1 location(s) · British Columbia Cancer Agency · NCT06628102 Liquid Biopsy-Based Pre-Screening to Streamline LDCT Lung Cancer Screening in High-Risk Individuals
NA · 1 location(s) · National University Hospital, Singapore · NCT07358715 Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Phase N/A · 745 location(s) · Alliance for Clinical Trials in Oncology · NCT05334069 Lung Cancer Screening With Low-dose CT Scan in Women : Implementation Study
NA · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05195385 Tailored Patient Navigation to Improve the Uptake of Lung Cancer Screening in Tribal Communities in Western Washington S
NA · 2 location(s) · Fred Hutchinson Cancer Center · NCT07176000 Avera Cancer Sequencing and Analytics Protocol (ASAP)
Phase N/A · 6 location(s) · Avera McKennan Hospital & University Health Center · NCT05142033 Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Di
NA · 11 location(s) · bioAffinity Technologies Inc. · NCT07168993

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.